RhumbLine Advisers’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,473
Closed -$70K 3276
2022
Q1
$70K Sell
4,473
-6
-0.1% -$104 ﹤0.01% 2946
2021
Q4
$119K Sell
4,479
-48
-1% -$1.82K ﹤0.01% 2917
2021
Q3
$221K Buy
4,527
+155
+4% +$9.58K ﹤0.01% 2875
2021
Q2
$369K Sell
4,372
-615
-12% -$52.8K ﹤0.01% 2699
2021
Q1
$505K Sell
4,987
-23
-0.5% -$2.53K ﹤0.01% 2490
2020
Q4
$504K Buy
5,010
+986
+25% +$65.8K ﹤0.01% 2440
2020
Q3
$186K Buy
4,024
+798
+25% +$41K ﹤0.01% 2712
2020
Q2
$186K Buy
+3,226
New +$215K ﹤0.01% 2796

Other funds holding AWH

RhumbLine Advisers's AWH Position: Q2 2022 in Review

RhumbLine Advisers sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2022, closing a stake of 4,473 shares — an estimated $70K sold.

RhumbLine Advisers first reported a position in AWH in Q2 2020 and held it in 8 quarters. The position peaked at $505K in Q1 2021. 72 funds tracked by Wall St. Rank hold AWH as of Q2 2022.

  • RhumbLine Advisers reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 4,473 Aspira Women's Health Inc. Common Stock shares in Q2 2022, an estimated $70K.
  • RhumbLine Advisers first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • RhumbLine Advisers's Aspira Women's Health Inc. Common Stock position peaked at $505K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.